Acute Safety, Tolerability, Feasibility and Pharmacokinetics of Intrath. Administered ATI355 in Patients With Acute SCI
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the acute safety, tolerability, feasibility and pharmacokinetics of
6 dose regimens of ATI355 in acute spinal cord injury patients